Ethyl 2-(formylamino)-alpha-oxo-4-thiazoleacetate
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
64987-03-7CCOC(=O)C(=O)c1csc(NC=O)n1NTACMHVXGGGRQU-UHFFFAOYSA-NSicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (23.1%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 52 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Chemical: 4-Thiazoleacetic acid, 2-(formylamino)-.alpha.-oxo-, ethyl ester
REACH registered substance: Ethyl 2-formamido-α-oxothiazol-4-acetate (EC: 265-299-4)
VerwendenEthyl 2-(2-Formamidothiazol-4-yl)-2-oxoacetate is an intermediate formed in the synthesis of Cefixime Ethyl Ester Sodium Salt (C242830), an ester impurity of the third generation cephalosporin antibiotic, Cefixime (C242800).
64987-03-7DTXSID6057794CHEMBL3561164